Skip to main content
. 2018 Jun 19;8(3):2045894018787381. doi: 10.1177/2045894018787381

Table 1.

Patient characteristics at baseline.

n 10
Age (years) 66 (8.2)
Female (n (%)) 7 (70)
BMI (kg/m2) 29.6 (6.1)
Lung disease (n (%))
 No 5 (50)
 COPD 4 (40)
 ILD 1 (10)
Scleroderma (n (%)) 3 (30)
6-minute walk distance (m) 306 ± 148.2
Functional class (n (%))
 1 2 (25)
 2 4 (50)
 3 2 (25)
TRV (m/s) 2.7 (+/− 0.5)
FEV1 (%) 84 (29.9)
FVC (%) 91 (15.0)
DLco (%) 49 (20.9)
Use of medication for ePH
 Sildenafil 1
 Tadalafil* 7
 Ambrisentan / Tadalafil 1
 Riociguat 1
*

Tadalafil (40 mg = 6; 20 mg = 1).